Skip to main content
Top
Published in: Journal of Inherited Metabolic Disease 6/2012

01-11-2012 | Original Article

Maternal phenylketonuria: low phenylalaninemia might increase the risk of intra uterine growth retardation

Authors: Raphaël Teissier, Emmanuel Nowak, Murielle Assoun, Karine Mention, Aline Cano, Alain Fouilhoux, François Feillet, Hélène Ogier, Emmanuel Oger, Loïc de Parscau, On behalf of the AFDPHE (Association Française pour le Dépistage et la Prévention des Handicaps de l’Enfant)

Published in: Journal of Inherited Metabolic Disease | Issue 6/2012

Login to get access

Abstract

Background

Malformations and mental retardation in the offspring of women with Phenylketonuria (PKU) can be prevented by maintaining maternal blood Phenylalanine (PHE) within a target range (120–300 μmol/L) through a PHE-restricted diet. In a former French study, a high and unexpected proportion of intra uterine growth retardation (IUGR) has been reported. Guidelines have been proposed to all French centres caring for maternal PKU since 2002.

Objective

To confirm IUGR and investigate its causes. The other goals were to assess the follow-up of these pregnancies based on the new guidelines and the pertinence of these recommendations.

Design

Clinical, biological and ultrasound data of all pregnancies in PKU women in France, from 2002 to 2007 were retrospectively analyzed.

Results

Data from 115 pregnancies in 86 women with PKU were collected. Ninety percent of women had been informed of the risk of maternal PKU in the absence of a strict diet during pregnancy, 88 % of women had started a diet before conception, and 45 % of infants were born small for gestational age (birth length and/or weight ≤−2 SD). PHE intakes were lower in the group with IUGR from the fifth to the eighth month of pregnancy and duration of time spent at <120 μmol/L during pregnancy was associated with a higher risk of IUGR.

Conclusion

Hyperphenylalaninemia (HPA) is not the only risk factor for IUGR; PHE lower than 120 μmol/L could also be associated with the IUGR occurence. Even if the monitoring of these pregnancies has been improved since the initiation of guidelines, we would like to stress on the importance of the dietary aspect of the disease.
Literature
go back to reference Abadie V, Depondt E, Bresson JL, Vidailhet M (2001) Recommandations diététiques pour les femmes enceintes atteintes de phénylcétonurie. Arch Pediatr 8:397–406PubMedCrossRef Abadie V, Depondt E, Bresson JL, Vidailhet M (2001) Recommandations diététiques pour les femmes enceintes atteintes de phénylcétonurie. Arch Pediatr 8:397–406PubMedCrossRef
go back to reference Bhasin KK, van Nas A, Martin LJ, Davis RC, Devaskar SU, Lusis AJ (2009) Maternal low-protein diet or hypercholesterolemia reduces circulating essential amino acids and leads to intrauterine growth restriction. Diabetes 58:559–566PubMedCrossRef Bhasin KK, van Nas A, Martin LJ, Davis RC, Devaskar SU, Lusis AJ (2009) Maternal low-protein diet or hypercholesterolemia reduces circulating essential amino acids and leads to intrauterine growth restriction. Diabetes 58:559–566PubMedCrossRef
go back to reference Carmichael S, Abrams B, Selvin S (1997) The pattern of maternal weight gain in women with good pregnancy outcomes. Am J Public Health 87(12):1984–1988PubMedCrossRef Carmichael S, Abrams B, Selvin S (1997) The pattern of maternal weight gain in women with good pregnancy outcomes. Am J Public Health 87(12):1984–1988PubMedCrossRef
go back to reference Cho SW, Cha YS (2005) Pregnancy increases urinary loss of carnitine and reduces plasma carnitine in Korean women. Br J Nutr 93:685–691PubMedCrossRef Cho SW, Cha YS (2005) Pregnancy increases urinary loss of carnitine and reduces plasma carnitine in Korean women. Br J Nutr 93:685–691PubMedCrossRef
go back to reference Dubucquoi S, Caron C, Hennache B, Subtil D, Hachulla E (2005) Interprétation des examens biologiques au cours de la grossesse. Revue du Rhumatisme 72:698–706CrossRef Dubucquoi S, Caron C, Hennache B, Subtil D, Hachulla E (2005) Interprétation des examens biologiques au cours de la grossesse. Revue du Rhumatisme 72:698–706CrossRef
go back to reference Feillet F, Abadie V, Berthelot J, Maurin N, Ogier H, Vidailhet M et al (2004) Maternal phenylketonuria: the French survey. Eur J Pediatr 163:540–546PubMedCrossRef Feillet F, Abadie V, Berthelot J, Maurin N, Ogier H, Vidailhet M et al (2004) Maternal phenylketonuria: the French survey. Eur J Pediatr 163:540–546PubMedCrossRef
go back to reference Godfrey KM, Barker DJ (2000) Fetal nutrition and adult disease. Am J Clin Nutr 71(5 Suppl):1344S–1352SPubMed Godfrey KM, Barker DJ (2000) Fetal nutrition and adult disease. Am J Clin Nutr 71(5 Suppl):1344S–1352SPubMed
go back to reference Hagenfeldt L, Bjerkenstedt L, Edman G, Sedvall G, Wiesel FA (1984) Amino acids in plasma and CSF and monoamine metabolites in CSF: interrelationship in healthy subjects. J Neurochem 42(3):833–837PubMedCrossRef Hagenfeldt L, Bjerkenstedt L, Edman G, Sedvall G, Wiesel FA (1984) Amino acids in plasma and CSF and monoamine metabolites in CSF: interrelationship in healthy subjects. J Neurochem 42(3):833–837PubMedCrossRef
go back to reference Institute of Medicine (US) and National Research Council (US) Committee to Reexamine IOM Pregnancy Weight Guidelines (2009) In: Rasmussen KM, Yaktine AL (eds) Weight Gain During Pregnancy: Reexamining the Guidelines. Washington (DC): National Academies Press (US) Institute of Medicine (US) and National Research Council (US) Committee to Reexamine IOM Pregnancy Weight Guidelines (2009) In: Rasmussen KM, Yaktine AL (eds) Weight Gain During Pregnancy: Reexamining the Guidelines. Washington (DC): National Academies Press (US)
go back to reference Koch R, Friedman E, Azen C, Hanley W, Levy H, Matalon R et al (2000) The international collaborative study of maternal phenylketonuria: status report 1998. Eur J Pediatr 159:156–160CrossRef Koch R, Friedman E, Azen C, Hanley W, Levy H, Matalon R et al (2000) The international collaborative study of maternal phenylketonuria: status report 1998. Eur J Pediatr 159:156–160CrossRef
go back to reference Koch R, Hanley W, Levy H, Matalon K, Matalon R, Rouse B et al (2003) The maternal phenylketonuria international study: 1984–2002. Pediatrics 112:1523–1529PubMed Koch R, Hanley W, Levy H, Matalon K, Matalon R, Rouse B et al (2003) The maternal phenylketonuria international study: 1984–2002. Pediatrics 112:1523–1529PubMed
go back to reference Lee PA, Chernausek SD, Hokken-Koelega AC, Czernichow P, International Small for Gestational Age Advisory Board (2003) International small for gestational Age advisory board consensus development conference statement: management of short children born small for gestational age, April 24-October 1, 2001. Pediatrics 111:1253–1261PubMedCrossRef Lee PA, Chernausek SD, Hokken-Koelega AC, Czernichow P, International Small for Gestational Age Advisory Board (2003) International small for gestational Age advisory board consensus development conference statement: management of short children born small for gestational age, April 24-October 1, 2001. Pediatrics 111:1253–1261PubMedCrossRef
go back to reference Lee PJ, Ridout D, Walter JH, Cockburn F (2005) Maternal phenylketonuria: report from the United Kingdom Registry 1978–97. Arch Dis Child 90:143–146PubMedCrossRef Lee PJ, Ridout D, Walter JH, Cockburn F (2005) Maternal phenylketonuria: report from the United Kingdom Registry 1978–97. Arch Dis Child 90:143–146PubMedCrossRef
go back to reference Lenke RR, Levy HL (1980) Maternal phenylketonuria and hyperphenylalaninemia. An international survey of the outcome of untreated and treated pregnancies. N Engl J Med 303:1202–1208PubMedCrossRef Lenke RR, Levy HL (1980) Maternal phenylketonuria and hyperphenylalaninemia. An international survey of the outcome of untreated and treated pregnancies. N Engl J Med 303:1202–1208PubMedCrossRef
go back to reference Levy HL, Guldberg P, Güttler F et al (2001) Congenital heart disease in maternal phenylketonuria: report from the maternal PKU collaborative study. Pediatr Res 49:636–642PubMedCrossRef Levy HL, Guldberg P, Güttler F et al (2001) Congenital heart disease in maternal phenylketonuria: report from the maternal PKU collaborative study. Pediatr Res 49:636–642PubMedCrossRef
go back to reference Maillot F, Lilburn M, Baudin J, Morley DW, Lee PJ (2008) Factors influencing outcomes in the offspring of mothers with phenylketonuria during pregnancy: the importance of variation in maternal blood phenylalanine. Am J Clin Nutr 88:700–705PubMed Maillot F, Lilburn M, Baudin J, Morley DW, Lee PJ (2008) Factors influencing outcomes in the offspring of mothers with phenylketonuria during pregnancy: the importance of variation in maternal blood phenylalanine. Am J Clin Nutr 88:700–705PubMed
go back to reference Niklasson A, Ericson A, Fryer JG, Karlberg J, Lawrence C, Karlberg P (1991) An update of the Swedish reference standards for weight, length and head circumference at birth for given gestational age (1977–1981). Acta Paediatr Scand 80:756–762PubMedCrossRef Niklasson A, Ericson A, Fryer JG, Karlberg J, Lawrence C, Karlberg P (1991) An update of the Swedish reference standards for weight, length and head circumference at birth for given gestational age (1977–1981). Acta Paediatr Scand 80:756–762PubMedCrossRef
go back to reference Report of Medical Research Council Working Party on Phenylketonuria (1993) Recommendations on the dietary management of phenylketonuria. Arch Dis Child 68(3):426–427 Report of Medical Research Council Working Party on Phenylketonuria (1993) Recommendations on the dietary management of phenylketonuria. Arch Dis Child 68(3):426–427
go back to reference Rohr FJ, Lobbregt D, Levy HL (1998) Tyrosine supplementation in the treatment of maternal phenylketonuria. Am J Clin Nutr 67:473–476PubMed Rohr FJ, Lobbregt D, Levy HL (1998) Tyrosine supplementation in the treatment of maternal phenylketonuria. Am J Clin Nutr 67:473–476PubMed
go back to reference Rouse B, Azen C, Koch R, Matalon R, Hanley W, de la Cruz F et al. (1997) Maternal Phenylketonuria Collaborative study (MPKUCS) offspring: facial anomalies, malformations, and early neurological sequelae. Am J Med Genet 69:89–95PubMedCrossRef Rouse B, Azen C, Koch R, Matalon R, Hanley W, de la Cruz F et al. (1997) Maternal Phenylketonuria Collaborative study (MPKUCS) offspring: facial anomalies, malformations, and early neurological sequelae. Am J Med Genet 69:89–95PubMedCrossRef
go back to reference Usher R, McLean F (1969) Intrauterine growth of live-born Caucasian infants at sea level: standards obtained from measurements in 7 dimensions of infants born between 25 and 44 weeks of gestation. J Pediatr 74:901–910PubMedCrossRef Usher R, McLean F (1969) Intrauterine growth of live-born Caucasian infants at sea level: standards obtained from measurements in 7 dimensions of infants born between 25 and 44 weeks of gestation. J Pediatr 74:901–910PubMedCrossRef
go back to reference Van Spronsen FJ, van Dijk T, Smit GP, van Rijn M, Reijngoud DJ, Berger R, Heymans HS (1996) Large daily fluctuations in plasma tyrosine in treated patients with phenylketonuria. Am J Clin Nutr 64(6):916–921 Van Spronsen FJ, van Dijk T, Smit GP, van Rijn M, Reijngoud DJ, Berger R, Heymans HS (1996) Large daily fluctuations in plasma tyrosine in treated patients with phenylketonuria. Am J Clin Nutr 64(6):916–921
go back to reference Van Spronsen FJ, van Rijn M, Bekhof J, Koch R, Smit PG (2001) Phenylketonuria: tyrosine supplementation in phenylalanine-restricted diets. Am J Clin Nutr 73(2):153–157PubMed Van Spronsen FJ, van Rijn M, Bekhof J, Koch R, Smit PG (2001) Phenylketonuria: tyrosine supplementation in phenylalanine-restricted diets. Am J Clin Nutr 73(2):153–157PubMed
go back to reference Waisbren SE, Hamilton BD, St James PJ, Shiloh S, Levy HL (1995) Psychosocial factors in maternal phenylketonuria: women's adherence to medical recommendations. Am J Public Health 85:1636–1641PubMedCrossRef Waisbren SE, Hamilton BD, St James PJ, Shiloh S, Levy HL (1995) Psychosocial factors in maternal phenylketonuria: women's adherence to medical recommendations. Am J Public Health 85:1636–1641PubMedCrossRef
Metadata
Title
Maternal phenylketonuria: low phenylalaninemia might increase the risk of intra uterine growth retardation
Authors
Raphaël Teissier
Emmanuel Nowak
Murielle Assoun
Karine Mention
Aline Cano
Alain Fouilhoux
François Feillet
Hélène Ogier
Emmanuel Oger
Loïc de Parscau
On behalf of the AFDPHE (Association Française pour le Dépistage et la Prévention des Handicaps de l’Enfant)
Publication date
01-11-2012
Publisher
Springer Netherlands
Published in
Journal of Inherited Metabolic Disease / Issue 6/2012
Print ISSN: 0141-8955
Electronic ISSN: 1573-2665
DOI
https://doi.org/10.1007/s10545-012-9491-0

Other articles of this Issue 6/2012

Journal of Inherited Metabolic Disease 6/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.